Nabeel  Ahmed net worth and biography

Nabeel Ahmed Biography and Net Worth

Nabeel Ahmed joined Outset in May 2020 as the company’s Vice President, Controller, and stepped in as interim CFO in July 2021, before being appointed CFO in August 2021. Prior to joining Outset Medical, Nabeel served as Vice President, Finance at 8×8, Inc., a communications platform provider and as Vice President, Finance at Vocera Communications, Inc. Previously, he held various leadership positions in accounting and finance, including as CFO of Wanderful Media as well as CFO of MarketTools, Inc.. Earlier in his career, Nabeel held various positions of increasing responsibility at Ernst & Young LLP and eBay, Inc. Mr. Ahmed holds a Bachelor of Commerce from Laurentian University and an MBA from The Wharton School, University of Pennsylvania.

What is Nabeel Ahmed's net worth?

The estimated net worth of Nabeel Ahmed is at least $725,218.08 as of February 15th, 2024. Mr. Ahmed owns 312,594 shares of Outset Medical stock worth more than $725,218 as of April 19th. This net worth estimate does not reflect any other assets that Mr. Ahmed may own. Additionally, Mr. Ahmed receives a salary of $654,740.00 as VP at Outset Medical. Learn More about Nabeel Ahmed's net worth.

How old is Nabeel Ahmed?

Mr. Ahmed is currently 48 years old. There are 5 older executives and no younger executives at Outset Medical. The oldest executive at Outset Medical is Mr. Mark Gordon M.S., Chief Regulatory & Quality Officer, who is 67 years old. Learn More on Nabeel Ahmed's age.

What is Nabeel Ahmed's salary?

As the VP of Outset Medical, Inc., Mr. Ahmed earns $654,740.00 per year. The highest earning executive at Outset Medical is Ms. Leslie L. Trigg, President, CEO & Chairman, who commands a salary of $1,220,000.00 per year. Learn More on Nabeel Ahmed's salary.

How do I contact Nabeel Ahmed?

The corporate mailing address for Mr. Ahmed and other Outset Medical executives is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. Outset Medical can also be reached via phone at 669-231-8200 and via email at [email protected]. Learn More on Nabeel Ahmed's contact information.

Has Nabeel Ahmed been buying or selling shares of Outset Medical?

Nabeel Ahmed has not been actively trading shares of Outset Medical during the last quarter. Most recently, Nabeel Ahmed sold 4,403 shares of the business's stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $3.57, for a transaction totalling $15,718.71. Following the completion of the sale, the chief financial officer now directly owns 312,594 shares of the company's stock, valued at $1,115,960.58. Learn More on Nabeel Ahmed's trading history.

Who are Outset Medical's active insiders?

Outset Medical's insider roster includes Nabeel Ahmed (VP), John Brottem (General Counsel), Rebecca Chambers (CFO), D. Grossman (Director), James Hinrichs (Director), Leslie Trigg (CEO), Martin Vazquez (COO), and Steven Williamson (Insider). Learn More on Outset Medical's active insiders.

Are insiders buying or selling shares of Outset Medical?

In the last year, insiders at the sold shares 34 times. They sold a total of 183,768 shares worth more than $2,821,339.29. The most recent insider tranaction occured on March, 15th when SVP Marc Nash sold 2,391 shares worth more than $5,092.83. Insiders at Outset Medical own 3.7% of the company. Learn More about insider trades at Outset Medical.

Information on this page was last updated on 3/15/2024.

Nabeel Ahmed Insider Trading History at Outset Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/15/2024Sell4,403$3.57$15,718.71312,594View SEC Filing Icon  
1/16/2024Sell1,726$4.29$7,404.54316,997View SEC Filing Icon  
1/8/2024Sell10,709$5.49$58,792.4176,819View SEC Filing Icon  
9/1/2023Sell545$13.61$7,417.4589,171View SEC Filing Icon  
7/3/2023Sell990$21.70$21,483.0091,726View SEC Filing Icon  
6/1/2023Sell990$20.83$20,621.7092,716View SEC Filing Icon  
5/16/2023Sell1,532$19.91$30,502.1293,706View SEC Filing Icon  
5/3/2023Sell990$20.00$19,800.0095,238View SEC Filing Icon  
2/16/2023Sell1,559$24.36$37,977.2495,350View SEC Filing Icon  
1/27/2023Sell4,938$27.92$137,868.9696,909View SEC Filing Icon  
8/16/2022Sell121$21.48$2,599.0842,413View SEC Filing Icon  
7/19/2022Sell787$16.56$13,032.7243,582View SEC Filing Icon  
5/17/2022Sell120$26.36$3,163.2044,369View SEC Filing Icon  
5/2/2022Sell200$35.00$7,000.0044,489View SEC Filing Icon  
4/1/2022Sell300$45.19$13,557.0044,489View SEC Filing Icon  
3/24/2022Sell424$42.65$18,083.60View SEC Filing Icon  
3/9/2022Sell477$41.72$19,900.44View SEC Filing Icon  
8/10/2021Buy1,000$37.13$37,130.0015,189View SEC Filing Icon  
See Full Table

Nabeel Ahmed Buying and Selling Activity at Outset Medical

This chart shows Nabeel Ahmed's buying and selling at Outset Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Outset Medical Company Overview

Outset Medical logo
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Read More

Today's Range

Now: $2.32
Low: $2.20
High: $2.36

50 Day Range

MA: $2.66
Low: $1.94
High: $3.79

2 Week Range

Now: $2.32
Low: $1.92
High: $24.13

Volume

825,129 shs

Average Volume

1,048,069 shs

Market Capitalization

$119.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.99